SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-280002
Filing Date
2015-08-06
Accepted
2015-08-06 08:10:55
Documents
13
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d77680d10q.htm 10-Q 520393
2 EX-10.1 d77680dex101.htm EX-10.1 817394
3 EX-31.1 d77680dex311.htm EX-31.1 6372
4 EX-31.2 d77680dex312.htm EX-31.2 6415
5 EX-32.1 d77680dex321.htm EX-32.1 3814
12 GRAPHIC g77680ex10_1pg141.jpg GRAPHIC 8574
13 GRAPHIC g77680g89o67.jpg GRAPHIC 135690
  Complete submission text file 0001193125-15-280002.txt   3755015

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT epzm-20150630.xml EX-101.INS 400454
7 XBRL TAXONOMY EXTENSION SCHEMA epzm-20150630.xsd EX-101.SCH 37058
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20150630_cal.xml EX-101.CAL 48350
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20150630_def.xml EX-101.DEF 95787
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20150630_lab.xml EX-101.LAB 293934
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20150630_pre.xml EX-101.PRE 202747
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 151031198
SIC: 2834 Pharmaceutical Preparations